nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Infestation—Epirubicin—stomach cancer	0.000724	0.000724	CcSEcCtD
Tobramycin—Bronchitis—Doxorubicin—stomach cancer	0.000723	0.000723	CcSEcCtD
Tobramycin—Agranulocytosis—Methotrexate—stomach cancer	0.000722	0.000722	CcSEcCtD
Tobramycin—Chest pain—Docetaxel—stomach cancer	0.000714	0.000714	CcSEcCtD
Tobramycin—Myalgia—Docetaxel—stomach cancer	0.000714	0.000714	CcSEcCtD
Tobramycin—Renal failure—Epirubicin—stomach cancer	0.000712	0.000712	CcSEcCtD
Tobramycin—Asthenia—Irinotecan—stomach cancer	0.000711	0.000711	CcSEcCtD
Tobramycin—Neuropathy peripheral—Epirubicin—stomach cancer	0.00071	0.00071	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000709	0.000709	CcSEcCtD
Tobramycin—Cough—Capecitabine—stomach cancer	0.000709	0.000709	CcSEcCtD
Tobramycin—Stomatitis—Epirubicin—stomach cancer	0.000706	0.000706	CcSEcCtD
Tobramycin—Hypersensitivity—Fluorouracil—stomach cancer	0.000699	0.000699	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000698	0.000698	CcSEcCtD
Tobramycin—Myalgia—Capecitabine—stomach cancer	0.000692	0.000692	CcSEcCtD
Tobramycin—Chest pain—Capecitabine—stomach cancer	0.000692	0.000692	CcSEcCtD
Tobramycin—Confusional state—Docetaxel—stomach cancer	0.00069	0.00069	CcSEcCtD
Tobramycin—Pharyngitis—Methotrexate—stomach cancer	0.000689	0.000689	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000687	0.000687	CcSEcCtD
Tobramycin—Urinary tract disorder—Methotrexate—stomach cancer	0.000686	0.000686	CcSEcCtD
Tobramycin—Anaphylactic shock—Docetaxel—stomach cancer	0.000685	0.000685	CcSEcCtD
Tobramycin—Discomfort—Capecitabine—stomach cancer	0.000683	0.000683	CcSEcCtD
Tobramycin—Epistaxis—Epirubicin—stomach cancer	0.000683	0.000683	CcSEcCtD
Tobramycin—Urethral disorder—Methotrexate—stomach cancer	0.000681	0.000681	CcSEcCtD
Tobramycin—Weight decreased—Doxorubicin—stomach cancer	0.00068	0.00068	CcSEcCtD
Tobramycin—Sinusitis—Epirubicin—stomach cancer	0.000679	0.000679	CcSEcCtD
Tobramycin—Diarrhoea—Irinotecan—stomach cancer	0.000678	0.000678	CcSEcCtD
Tobramycin—Agranulocytosis—Epirubicin—stomach cancer	0.000676	0.000676	CcSEcCtD
Tobramycin—Nervous system disorder—Docetaxel—stomach cancer	0.000672	0.000672	CcSEcCtD
Tobramycin—Pruritus—Fluorouracil—stomach cancer	0.000671	0.000671	CcSEcCtD
Tobramycin—Thrombocytopenia—Docetaxel—stomach cancer	0.00067	0.00067	CcSEcCtD
Tobramycin—Infestation NOS—Doxorubicin—stomach cancer	0.00067	0.00067	CcSEcCtD
Tobramycin—Infestation—Doxorubicin—stomach cancer	0.00067	0.00067	CcSEcCtD
Tobramycin—Visual impairment—Methotrexate—stomach cancer	0.000669	0.000669	CcSEcCtD
Tobramycin—Confusional state—Capecitabine—stomach cancer	0.000668	0.000668	CcSEcCtD
Tobramycin—Skin disorder—Docetaxel—stomach cancer	0.000665	0.000665	CcSEcCtD
Tobramycin—Renal failure—Doxorubicin—stomach cancer	0.000659	0.000659	CcSEcCtD
Tobramycin—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000657	0.000657	CcSEcCtD
Tobramycin—Dizziness—Irinotecan—stomach cancer	0.000655	0.000655	CcSEcCtD
Tobramycin—Stomatitis—Doxorubicin—stomach cancer	0.000653	0.000653	CcSEcCtD
Tobramycin—Anorexia—Docetaxel—stomach cancer	0.000653	0.000653	CcSEcCtD
Tobramycin—Rhinitis—Epirubicin—stomach cancer	0.000652	0.000652	CcSEcCtD
Tobramycin—Nervous system disorder—Capecitabine—stomach cancer	0.00065	0.00065	CcSEcCtD
Tobramycin—Eye disorder—Methotrexate—stomach cancer	0.000649	0.000649	CcSEcCtD
Tobramycin—Diarrhoea—Fluorouracil—stomach cancer	0.000649	0.000649	CcSEcCtD
Tobramycin—Thrombocytopenia—Capecitabine—stomach cancer	0.000649	0.000649	CcSEcCtD
Tobramycin—Tinnitus—Methotrexate—stomach cancer	0.000648	0.000648	CcSEcCtD
Tobramycin—Pharyngitis—Epirubicin—stomach cancer	0.000645	0.000645	CcSEcCtD
Tobramycin—Skin disorder—Capecitabine—stomach cancer	0.000644	0.000644	CcSEcCtD
Tobramycin—Urinary tract disorder—Epirubicin—stomach cancer	0.000642	0.000642	CcSEcCtD
Tobramycin—Connective tissue disorder—Epirubicin—stomach cancer	0.000639	0.000639	CcSEcCtD
Tobramycin—Urethral disorder—Epirubicin—stomach cancer	0.000637	0.000637	CcSEcCtD
Tobramycin—Epistaxis—Doxorubicin—stomach cancer	0.000632	0.000632	CcSEcCtD
Tobramycin—Anorexia—Capecitabine—stomach cancer	0.000632	0.000632	CcSEcCtD
Tobramycin—Angiopathy—Methotrexate—stomach cancer	0.00063	0.00063	CcSEcCtD
Tobramycin—Vomiting—Irinotecan—stomach cancer	0.00063	0.00063	CcSEcCtD
Tobramycin—Sinusitis—Doxorubicin—stomach cancer	0.000629	0.000629	CcSEcCtD
Tobramycin—Immune system disorder—Methotrexate—stomach cancer	0.000627	0.000627	CcSEcCtD
Tobramycin—Dizziness—Fluorouracil—stomach cancer	0.000627	0.000627	CcSEcCtD
Tobramycin—Visual impairment—Epirubicin—stomach cancer	0.000627	0.000627	CcSEcCtD
Tobramycin—Mediastinal disorder—Methotrexate—stomach cancer	0.000626	0.000626	CcSEcCtD
Tobramycin—Agranulocytosis—Doxorubicin—stomach cancer	0.000625	0.000625	CcSEcCtD
Tobramycin—Rash—Irinotecan—stomach cancer	0.000625	0.000625	CcSEcCtD
Tobramycin—Dermatitis—Irinotecan—stomach cancer	0.000624	0.000624	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000624	0.000624	CcSEcCtD
Tobramycin—Headache—Irinotecan—stomach cancer	0.000621	0.000621	CcSEcCtD
Tobramycin—Paraesthesia—Docetaxel—stomach cancer	0.000615	0.000615	CcSEcCtD
Tobramycin—Dyspnoea—Docetaxel—stomach cancer	0.00061	0.00061	CcSEcCtD
Tobramycin—Eye disorder—Epirubicin—stomach cancer	0.000608	0.000608	CcSEcCtD
Tobramycin—Tinnitus—Epirubicin—stomach cancer	0.000606	0.000606	CcSEcCtD
Tobramycin—Erythema—Methotrexate—stomach cancer	0.000605	0.000605	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000604	0.000604	CcSEcCtD
Tobramycin—Vomiting—Fluorouracil—stomach cancer	0.000603	0.000603	CcSEcCtD
Tobramycin—Rhinitis—Doxorubicin—stomach cancer	0.000603	0.000603	CcSEcCtD
Tobramycin—Rash—Fluorouracil—stomach cancer	0.000598	0.000598	CcSEcCtD
Tobramycin—Dermatitis—Fluorouracil—stomach cancer	0.000598	0.000598	CcSEcCtD
Tobramycin—Pharyngitis—Doxorubicin—stomach cancer	0.000597	0.000597	CcSEcCtD
Tobramycin—Paraesthesia—Capecitabine—stomach cancer	0.000595	0.000595	CcSEcCtD
Tobramycin—Decreased appetite—Docetaxel—stomach cancer	0.000595	0.000595	CcSEcCtD
Tobramycin—Headache—Fluorouracil—stomach cancer	0.000594	0.000594	CcSEcCtD
Tobramycin—Urinary tract disorder—Doxorubicin—stomach cancer	0.000594	0.000594	CcSEcCtD
Tobramycin—Dysgeusia—Methotrexate—stomach cancer	0.000592	0.000592	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000591	0.000591	CcSEcCtD
Tobramycin—Connective tissue disorder—Doxorubicin—stomach cancer	0.000591	0.000591	CcSEcCtD
Tobramycin—Dyspnoea—Capecitabine—stomach cancer	0.000591	0.000591	CcSEcCtD
Tobramycin—Angiopathy—Epirubicin—stomach cancer	0.00059	0.00059	CcSEcCtD
Tobramycin—Urethral disorder—Doxorubicin—stomach cancer	0.00059	0.00059	CcSEcCtD
Tobramycin—Nausea—Irinotecan—stomach cancer	0.000588	0.000588	CcSEcCtD
Tobramycin—Immune system disorder—Epirubicin—stomach cancer	0.000587	0.000587	CcSEcCtD
Tobramycin—Mediastinal disorder—Epirubicin—stomach cancer	0.000586	0.000586	CcSEcCtD
Tobramycin—Pain—Docetaxel—stomach cancer	0.000586	0.000586	CcSEcCtD
Tobramycin—Back pain—Methotrexate—stomach cancer	0.000585	0.000585	CcSEcCtD
Tobramycin—Visual impairment—Doxorubicin—stomach cancer	0.00058	0.00058	CcSEcCtD
Tobramycin—Decreased appetite—Capecitabine—stomach cancer	0.000576	0.000576	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000572	0.000572	CcSEcCtD
Tobramycin—Vision blurred—Methotrexate—stomach cancer	0.00057	0.00057	CcSEcCtD
Tobramycin—Pain—Capecitabine—stomach cancer	0.000567	0.000567	CcSEcCtD
Tobramycin—Erythema—Epirubicin—stomach cancer	0.000566	0.000566	CcSEcCtD
Tobramycin—Feeling abnormal—Docetaxel—stomach cancer	0.000564	0.000564	CcSEcCtD
Tobramycin—Nausea—Fluorouracil—stomach cancer	0.000564	0.000564	CcSEcCtD
Tobramycin—Eye disorder—Doxorubicin—stomach cancer	0.000562	0.000562	CcSEcCtD
Tobramycin—Ill-defined disorder—Methotrexate—stomach cancer	0.000561	0.000561	CcSEcCtD
Tobramycin—Tinnitus—Doxorubicin—stomach cancer	0.000561	0.000561	CcSEcCtD
Tobramycin—Gastrointestinal pain—Docetaxel—stomach cancer	0.00056	0.00056	CcSEcCtD
Tobramycin—Anaemia—Methotrexate—stomach cancer	0.000559	0.000559	CcSEcCtD
Tobramycin—Dysgeusia—Epirubicin—stomach cancer	0.000554	0.000554	CcSEcCtD
Tobramycin—Back pain—Epirubicin—stomach cancer	0.000547	0.000547	CcSEcCtD
Tobramycin—Feeling abnormal—Capecitabine—stomach cancer	0.000546	0.000546	CcSEcCtD
Tobramycin—Angiopathy—Doxorubicin—stomach cancer	0.000546	0.000546	CcSEcCtD
Tobramycin—Malaise—Methotrexate—stomach cancer	0.000545	0.000545	CcSEcCtD
Tobramycin—Immune system disorder—Doxorubicin—stomach cancer	0.000543	0.000543	CcSEcCtD
Tobramycin—Vertigo—Methotrexate—stomach cancer	0.000543	0.000543	CcSEcCtD
Tobramycin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000542	0.000542	CcSEcCtD
Tobramycin—Mediastinal disorder—Doxorubicin—stomach cancer	0.000542	0.000542	CcSEcCtD
Tobramycin—Abdominal pain—Docetaxel—stomach cancer	0.000541	0.000541	CcSEcCtD
Tobramycin—Body temperature increased—Docetaxel—stomach cancer	0.000541	0.000541	CcSEcCtD
Tobramycin—Leukopenia—Methotrexate—stomach cancer	0.000541	0.000541	CcSEcCtD
Tobramycin—Vision blurred—Epirubicin—stomach cancer	0.000533	0.000533	CcSEcCtD
Tobramycin—Cough—Methotrexate—stomach cancer	0.000528	0.000528	CcSEcCtD
Tobramycin—Urticaria—Capecitabine—stomach cancer	0.000527	0.000527	CcSEcCtD
Tobramycin—Ill-defined disorder—Epirubicin—stomach cancer	0.000525	0.000525	CcSEcCtD
Tobramycin—Body temperature increased—Capecitabine—stomach cancer	0.000524	0.000524	CcSEcCtD
Tobramycin—Abdominal pain—Capecitabine—stomach cancer	0.000524	0.000524	CcSEcCtD
Tobramycin—Erythema—Doxorubicin—stomach cancer	0.000524	0.000524	CcSEcCtD
Tobramycin—Anaemia—Epirubicin—stomach cancer	0.000523	0.000523	CcSEcCtD
Tobramycin—Chest pain—Methotrexate—stomach cancer	0.000515	0.000515	CcSEcCtD
Tobramycin—Myalgia—Methotrexate—stomach cancer	0.000515	0.000515	CcSEcCtD
Tobramycin—Dysgeusia—Doxorubicin—stomach cancer	0.000513	0.000513	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000511	0.000511	CcSEcCtD
Tobramycin—Malaise—Epirubicin—stomach cancer	0.00051	0.00051	CcSEcCtD
Tobramycin—Discomfort—Methotrexate—stomach cancer	0.000509	0.000509	CcSEcCtD
Tobramycin—Vertigo—Epirubicin—stomach cancer	0.000508	0.000508	CcSEcCtD
Tobramycin—Leukopenia—Epirubicin—stomach cancer	0.000507	0.000507	CcSEcCtD
Tobramycin—Back pain—Doxorubicin—stomach cancer	0.000507	0.000507	CcSEcCtD
Tobramycin—Hypersensitivity—Docetaxel—stomach cancer	0.000505	0.000505	CcSEcCtD
Tobramycin—Confusional state—Methotrexate—stomach cancer	0.000498	0.000498	CcSEcCtD
Tobramycin—Cough—Epirubicin—stomach cancer	0.000494	0.000494	CcSEcCtD
Tobramycin—Anaphylactic shock—Methotrexate—stomach cancer	0.000494	0.000494	CcSEcCtD
Tobramycin—Vision blurred—Doxorubicin—stomach cancer	0.000493	0.000493	CcSEcCtD
Tobramycin—Asthenia—Docetaxel—stomach cancer	0.000491	0.000491	CcSEcCtD
Tobramycin—Hypersensitivity—Capecitabine—stomach cancer	0.000488	0.000488	CcSEcCtD
Tobramycin—Ill-defined disorder—Doxorubicin—stomach cancer	0.000486	0.000486	CcSEcCtD
Tobramycin—Pruritus—Docetaxel—stomach cancer	0.000484	0.000484	CcSEcCtD
Tobramycin—Nervous system disorder—Methotrexate—stomach cancer	0.000484	0.000484	CcSEcCtD
Tobramycin—Anaemia—Doxorubicin—stomach cancer	0.000484	0.000484	CcSEcCtD
Tobramycin—Thrombocytopenia—Methotrexate—stomach cancer	0.000483	0.000483	CcSEcCtD
Tobramycin—Chest pain—Epirubicin—stomach cancer	0.000482	0.000482	CcSEcCtD
Tobramycin—Myalgia—Epirubicin—stomach cancer	0.000482	0.000482	CcSEcCtD
Tobramycin—Skin disorder—Methotrexate—stomach cancer	0.000479	0.000479	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000478	0.000478	CcSEcCtD
Tobramycin—Discomfort—Epirubicin—stomach cancer	0.000476	0.000476	CcSEcCtD
Tobramycin—Asthenia—Capecitabine—stomach cancer	0.000476	0.000476	CcSEcCtD
Tobramycin—Malaise—Doxorubicin—stomach cancer	0.000472	0.000472	CcSEcCtD
Tobramycin—Vertigo—Doxorubicin—stomach cancer	0.00047	0.00047	CcSEcCtD
Tobramycin—Anorexia—Methotrexate—stomach cancer	0.00047	0.00047	CcSEcCtD
Tobramycin—Pruritus—Capecitabine—stomach cancer	0.000469	0.000469	CcSEcCtD
Tobramycin—Leukopenia—Doxorubicin—stomach cancer	0.000469	0.000469	CcSEcCtD
Tobramycin—Diarrhoea—Docetaxel—stomach cancer	0.000469	0.000469	CcSEcCtD
Tobramycin—Confusional state—Epirubicin—stomach cancer	0.000466	0.000466	CcSEcCtD
Tobramycin—Anaphylactic shock—Epirubicin—stomach cancer	0.000462	0.000462	CcSEcCtD
Tobramycin—Cough—Doxorubicin—stomach cancer	0.000457	0.000457	CcSEcCtD
Tobramycin—Diarrhoea—Capecitabine—stomach cancer	0.000454	0.000454	CcSEcCtD
Tobramycin—Nervous system disorder—Epirubicin—stomach cancer	0.000453	0.000453	CcSEcCtD
Tobramycin—Dizziness—Docetaxel—stomach cancer	0.000453	0.000453	CcSEcCtD
Tobramycin—Thrombocytopenia—Epirubicin—stomach cancer	0.000452	0.000452	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.00045	0.00045	CcSEcCtD
Tobramycin—Skin disorder—Epirubicin—stomach cancer	0.000449	0.000449	CcSEcCtD
Tobramycin—Chest pain—Doxorubicin—stomach cancer	0.000446	0.000446	CcSEcCtD
Tobramycin—Myalgia—Doxorubicin—stomach cancer	0.000446	0.000446	CcSEcCtD
Tobramycin—Paraesthesia—Methotrexate—stomach cancer	0.000443	0.000443	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000443	0.000443	CcSEcCtD
Tobramycin—Discomfort—Doxorubicin—stomach cancer	0.00044	0.00044	CcSEcCtD
Tobramycin—Anorexia—Epirubicin—stomach cancer	0.00044	0.00044	CcSEcCtD
Tobramycin—Dyspnoea—Methotrexate—stomach cancer	0.00044	0.00044	CcSEcCtD
Tobramycin—Dizziness—Capecitabine—stomach cancer	0.000438	0.000438	CcSEcCtD
Tobramycin—Vomiting—Docetaxel—stomach cancer	0.000435	0.000435	CcSEcCtD
Tobramycin—Rash—Docetaxel—stomach cancer	0.000432	0.000432	CcSEcCtD
Tobramycin—Dermatitis—Docetaxel—stomach cancer	0.000431	0.000431	CcSEcCtD
Tobramycin—Confusional state—Doxorubicin—stomach cancer	0.000431	0.000431	CcSEcCtD
Tobramycin—Decreased appetite—Methotrexate—stomach cancer	0.000429	0.000429	CcSEcCtD
Tobramycin—Headache—Docetaxel—stomach cancer	0.000429	0.000429	CcSEcCtD
Tobramycin—Anaphylactic shock—Doxorubicin—stomach cancer	0.000427	0.000427	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000426	0.000426	CcSEcCtD
Tobramycin—Pain—Methotrexate—stomach cancer	0.000422	0.000422	CcSEcCtD
Tobramycin—Vomiting—Capecitabine—stomach cancer	0.000422	0.000422	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000421	0.000421	CcSEcCtD
Tobramycin—Nervous system disorder—Doxorubicin—stomach cancer	0.000419	0.000419	CcSEcCtD
Tobramycin—Thrombocytopenia—Doxorubicin—stomach cancer	0.000418	0.000418	CcSEcCtD
Tobramycin—Rash—Capecitabine—stomach cancer	0.000418	0.000418	CcSEcCtD
Tobramycin—Dermatitis—Capecitabine—stomach cancer	0.000418	0.000418	CcSEcCtD
Tobramycin—Headache—Capecitabine—stomach cancer	0.000415	0.000415	CcSEcCtD
Tobramycin—Skin disorder—Doxorubicin—stomach cancer	0.000415	0.000415	CcSEcCtD
Tobramycin—Paraesthesia—Epirubicin—stomach cancer	0.000415	0.000415	CcSEcCtD
Tobramycin—Dyspnoea—Epirubicin—stomach cancer	0.000412	0.000412	CcSEcCtD
Tobramycin—Anorexia—Doxorubicin—stomach cancer	0.000407	0.000407	CcSEcCtD
Tobramycin—Nausea—Docetaxel—stomach cancer	0.000407	0.000407	CcSEcCtD
Tobramycin—Feeling abnormal—Methotrexate—stomach cancer	0.000407	0.000407	CcSEcCtD
Tobramycin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000404	0.000404	CcSEcCtD
Tobramycin—Decreased appetite—Epirubicin—stomach cancer	0.000402	0.000402	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000399	0.000399	CcSEcCtD
Tobramycin—Pain—Epirubicin—stomach cancer	0.000395	0.000395	CcSEcCtD
Tobramycin—Nausea—Capecitabine—stomach cancer	0.000394	0.000394	CcSEcCtD
Tobramycin—Urticaria—Methotrexate—stomach cancer	0.000392	0.000392	CcSEcCtD
Tobramycin—Body temperature increased—Methotrexate—stomach cancer	0.00039	0.00039	CcSEcCtD
Tobramycin—Abdominal pain—Methotrexate—stomach cancer	0.00039	0.00039	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000389	0.000389	CcSEcCtD
Tobramycin—Paraesthesia—Doxorubicin—stomach cancer	0.000384	0.000384	CcSEcCtD
Tobramycin—Dyspnoea—Doxorubicin—stomach cancer	0.000381	0.000381	CcSEcCtD
Tobramycin—Feeling abnormal—Epirubicin—stomach cancer	0.000381	0.000381	CcSEcCtD
Tobramycin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000378	0.000378	CcSEcCtD
Tobramycin—Decreased appetite—Doxorubicin—stomach cancer	0.000372	0.000372	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000369	0.000369	CcSEcCtD
Tobramycin—Urticaria—Epirubicin—stomach cancer	0.000367	0.000367	CcSEcCtD
Tobramycin—Pain—Doxorubicin—stomach cancer	0.000365	0.000365	CcSEcCtD
Tobramycin—Abdominal pain—Epirubicin—stomach cancer	0.000365	0.000365	CcSEcCtD
Tobramycin—Body temperature increased—Epirubicin—stomach cancer	0.000365	0.000365	CcSEcCtD
Tobramycin—Hypersensitivity—Methotrexate—stomach cancer	0.000364	0.000364	CcSEcCtD
Tobramycin—Asthenia—Methotrexate—stomach cancer	0.000354	0.000354	CcSEcCtD
Tobramycin—Feeling abnormal—Doxorubicin—stomach cancer	0.000352	0.000352	CcSEcCtD
Tobramycin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000349	0.000349	CcSEcCtD
Tobramycin—Pruritus—Methotrexate—stomach cancer	0.000349	0.000349	CcSEcCtD
Tobramycin—Hypersensitivity—Epirubicin—stomach cancer	0.00034	0.00034	CcSEcCtD
Tobramycin—Urticaria—Doxorubicin—stomach cancer	0.00034	0.00034	CcSEcCtD
Tobramycin—Abdominal pain—Doxorubicin—stomach cancer	0.000338	0.000338	CcSEcCtD
Tobramycin—Body temperature increased—Doxorubicin—stomach cancer	0.000338	0.000338	CcSEcCtD
Tobramycin—Diarrhoea—Methotrexate—stomach cancer	0.000338	0.000338	CcSEcCtD
Tobramycin—Asthenia—Epirubicin—stomach cancer	0.000331	0.000331	CcSEcCtD
Tobramycin—Pruritus—Epirubicin—stomach cancer	0.000327	0.000327	CcSEcCtD
Tobramycin—Dizziness—Methotrexate—stomach cancer	0.000326	0.000326	CcSEcCtD
Tobramycin—Diarrhoea—Epirubicin—stomach cancer	0.000316	0.000316	CcSEcCtD
Tobramycin—Hypersensitivity—Doxorubicin—stomach cancer	0.000315	0.000315	CcSEcCtD
Tobramycin—Vomiting—Methotrexate—stomach cancer	0.000314	0.000314	CcSEcCtD
Tobramycin—Rash—Methotrexate—stomach cancer	0.000311	0.000311	CcSEcCtD
Tobramycin—Dermatitis—Methotrexate—stomach cancer	0.000311	0.000311	CcSEcCtD
Tobramycin—Headache—Methotrexate—stomach cancer	0.000309	0.000309	CcSEcCtD
Tobramycin—Asthenia—Doxorubicin—stomach cancer	0.000307	0.000307	CcSEcCtD
Tobramycin—Dizziness—Epirubicin—stomach cancer	0.000305	0.000305	CcSEcCtD
Tobramycin—Pruritus—Doxorubicin—stomach cancer	0.000302	0.000302	CcSEcCtD
Tobramycin—Vomiting—Epirubicin—stomach cancer	0.000294	0.000294	CcSEcCtD
Tobramycin—Nausea—Methotrexate—stomach cancer	0.000293	0.000293	CcSEcCtD
Tobramycin—Diarrhoea—Doxorubicin—stomach cancer	0.000292	0.000292	CcSEcCtD
Tobramycin—Rash—Epirubicin—stomach cancer	0.000291	0.000291	CcSEcCtD
Tobramycin—Dermatitis—Epirubicin—stomach cancer	0.000291	0.000291	CcSEcCtD
Tobramycin—Headache—Epirubicin—stomach cancer	0.000289	0.000289	CcSEcCtD
Tobramycin—Dizziness—Doxorubicin—stomach cancer	0.000283	0.000283	CcSEcCtD
Tobramycin—Nausea—Epirubicin—stomach cancer	0.000274	0.000274	CcSEcCtD
Tobramycin—Vomiting—Doxorubicin—stomach cancer	0.000272	0.000272	CcSEcCtD
Tobramycin—Rash—Doxorubicin—stomach cancer	0.000269	0.000269	CcSEcCtD
Tobramycin—Dermatitis—Doxorubicin—stomach cancer	0.000269	0.000269	CcSEcCtD
Tobramycin—Headache—Doxorubicin—stomach cancer	0.000268	0.000268	CcSEcCtD
Tobramycin—Nausea—Doxorubicin—stomach cancer	0.000254	0.000254	CcSEcCtD
